Medirays Biotech Private Limited
About Medirays Biotech Private Limited
Data last updated:
Medirays Biotech Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the optical and photographic instruments segment of the manufacturing sector. It was incorporated on 19 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33208MH2019PTC329443.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suman Rakesh Yadav and Rakesh Ramkeval Yadav.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at B – 305 Khushi Apt Nr Hari Dham Nilemore Nallasopara West Thane, Mumbai, Maharashtra, India – 400023.
As per the financials filed for FY 2023, the company reported a revenue of ₹25,000, a decline of 81% compared to the previous year. For the same year it recorded a net loss of ₹1,495 (net margin -6%) and EBITDA of -₹1,495 (EBITDA margin -6%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years.
Company details
Contact details
Medirays Biotech Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressB – 305 Khushi Apt Nr Hari Dham Nilemore Nallasopara West Thane, Mumbai, Maharashtra, India – 400023
- IndustryManufacturing, Optical & Photographic Instruments, Manufacturing
To see the full contact details of Medirays Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medirays Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medirays Biotech Private Limited, buy the company report.
Financials of Medirays Biotech Private Limited
FY 2023 filings availableMedirays Biotech Private Limited reported revenue of ₹25,000 (down 81% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 28% over three years, including a 81% fall in the latest year. EBITDA rose 57% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1,495 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1,495 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -6% | |||
| Net Profit Margin | -6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medirays Biotech Private Limited, buy the company report.
Board of directors of Medirays Biotech Private Limited
Medirays Biotech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Rakesh Yadav | Director | 19 Aug 2019 | 7 Years 2 Months | Current |
| Rakesh Ramkeval Yadav | Director | 19 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Medirays Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Al Zumzum Attar Manufacturing and Exports Private Limited | ₹26,000 (FY 2018) | Gardanibagh, Patna, Bihar, India | ||||
| Zenorex Pharmaceutical Private Limited | ₹25,453 (FY 2019) | Ghaziabad, Uttar Pradesh, India | ||||
| Ak Diabetic Herbal Private Limited | ₹25,300 (FY 2018) | -32.0% | Kanpur, Uttar Pradesh, India | |||
| Medclear Healthcare Private Limited | ₹25,034 (FY 2025) | -36.0% | Hyderabad, Telangana, India | |||
| Medirays Biotech Private Limitedthis company | ₹25,000 (FY 2023) | -₹1,495 | -6% | -81.0% | Mumbai, Maharashtra, India | |
| Aspam Petrochem Private Limited | ₹25,000 (FY 2025) | Delhi, India | ||||
| Himvayu Innovators Private Limited | ₹25,000 (FY 2024) | Lucknow, Uttar Pradesh, India | ||||
| Brahmaved Private Limited | ₹24,875 (FY 2024) | -61.0% | Pune, Maharashtra, India | |||
| Manmart Healthcare Private Limited | ₹24,800 (FY 2020) | -97.0% | Chandigarh, India | |||
| Pole Star Biotech Private Limited | ₹24,600 (FY 2025) | -68.0% | Gorakhpur, Uttar Pradesh, India | |||
| Danev Healthcare Private Limited | ₹24,376 (FY 2022) | -75.0% | Panoli, Gujarat, India |
To see the full peer comparison of Medirays Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medirays Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medirays Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medirays Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medirays Biotech Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Rakesh Ramkeval Yadav was appointed as Director on 19 Aug 2019.
Frequently asked questions
Medirays Biotech is an active private limited company based in Mumbai, Maharashtra, India. The company works in optical and photographic instruments, within the manufacturing industry. It was incorporated on 19 August 2019 (7+ years old) and is registered under CIN U33208MH2019PTC329443.
Medirays Biotech has 2 current directors:
- Suman Rakesh Yadav - Director
- Rakesh Ramkeval Yadav - Director
The latest financial statements of Medirays Biotech on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Medirays Biotech is U33208MH2019PTC329443. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medirays Biotech was incorporated on 19 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medirays Biotech by revenue are Al Zumzum Attar Manufacturing and Exports Private Limited, Zenorex Pharmaceutical Private Limited, Ak Diabetic Herbal Private Limited, Medclear Healthcare Private Limited, Aspam Petrochem Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rakesh Ramkeval Yadav was appointed as Director on 19 Aug 2019. Suman Rakesh Yadav was appointed as Director on 19 Aug 2019.
The registered office of Medirays Biotech is at B – 305 Khushi Apt Nr Hari Dham Nilemore Nallasopara West Thane, Mumbai, Maharashtra, India – 400023.
Medirays Biotech operates in the manufacturing industry, in the optical and photographic instruments segment.
Medirays Biotech can be reached at its registered office: B – 305 Khushi Apt Nr Hari Dham Nilemore Nallasopara West Thane, Mumbai, Maharashtra, India – 400023.
Medirays Biotech is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
